Synthesis and evaluations of selective COX-2 inhibitory effects: Benzo[d] thiazol analogs

被引:8
作者
He, Li-Ya [1 ]
Zhang, Shan-Shan [1 ]
Peng, Ding-Xin [1 ]
Guan, Li-Ping [1 ]
Wang, Si-Hong [2 ]
机构
[1] Zhejiang Ocean Univ, Food & Pharm Coll, Zhoushan 316022, Zhejiang, Peoples R China
[2] Yanbian Univ, Minist Educ, Key Lab Nat Resource Changbai Mt & Functiaonal Mo, Yanji 133000, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
Benzo[d]thiazol; Synthesis; Anti-inflammatory; Analgesic; COX-2; inhibitors; BIOLOGICAL EVALUATION; IN-VITRO; DESIGN; DERIVATIVES; BENZOTHIAZOLE; ESTERS;
D O I
10.1016/j.bmcl.2020.127376
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of benzo[d]thiazole analogs were synthesized and evaluated for their anti-inflammatory and analgesic effects. Using an ear edema model, except for compounds 2k, 2m-2q and 3a, other compounds showed the anti-inflammatory effects. Among them, compounds 2c, 2d, and 2g showed the best anti-inflammatory activity (inhibition rate: 86.8%, 90.7% and 82.9%, respectively). By the acetic acid-induced abdominal writhing test, except for compounds 2e, 2l, 2m, 2o, 2p and 3a, other compounds showed the analgesic effects with inhibition rate values of 51.9-100% (2a-2r) and 68.6-100% (3a-3g). Next, compounds 2c, 2d, 2g, 3d, 3f, 3g that displayed the excellent anti-inflammatory and analgesic activities were evaluated for their inhibitory effect against ovine COX-1 and COX-2. Compounds 2c, 2d, 2g, 3d, 3f, 3g were weak inhibitors of the COX-1 isozyme but exhibited the moderate COX-2 isozyme inhibitory effects IC50 from 0.28 to 0.77 mu M and COX-2 selectivity indexes (SI: 18.6 to 7.2). This benzo[d]thiazole moiety will be proved to be of great significance for developing more potent COX-2 inhibitors.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] 2D QSAR STUDY OF INDOLE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS
    Chavan, R. S.
    More, H. N.
    Bhosale, A., V
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (07): : 3378 - 3385
  • [22] Synthesis of novel thiadiazole derivatives as selective COX-2 inhibitors
    Ragab, Fatma A.
    Heiba, Helmi I.
    El-Gazzar, Marwa G.
    Abou-Seri, Sahar M.
    El-Sabbagh, Walaa A.
    El-Hazek, Reham M.
    MEDCHEMCOMM, 2016, 7 (12) : 2309 - 2327
  • [23] Synthesis and Preliminary COX-2 Expression Inhibitory Activities of Andrographolide Derivatives
    Li, Jing
    Huang, Wenlong
    Zhang, Huibin
    Zhou, Huiping
    LETTERS IN DRUG DESIGN & DISCOVERY, 2010, 7 (03) : 176 - 181
  • [24] Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships
    Zarghi, Afshin
    Arfaei, Sara
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (04): : 655 - 683
  • [25] Synthesis of novel pyrazolyl tetrazoles as selective COX-2 inhibitors
    Swetha, Kolli Sri
    Parameshwar, Ravula
    Reddy, B. Madhava
    Babu, V. Harinadha
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (10) : 4886 - 4892
  • [26] Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases
    Rayar, Anita-Marie
    Lagarde, Nathalie
    Ferroud, Clotilde
    Zagury, Jean-Francois
    Montes, Matthieu
    Veitia, Maite Sylla-Iyarreta
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (26) : 2935 - 2956
  • [27] Design and synthesis of new 1,2-diaryl-4,5,6,7-tetrahydro-1H-benzo[d] imidazoles as selective cyclooxygenase (COX-2) inhibitors
    Zarghi, A.
    Reihanfard, H.
    Arfaei, S.
    Daraei, B.
    Hedayati, M.
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (08) : 1869 - 1875
  • [28] Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies
    Abdellatif, Khaled R. A.
    Abdelall, Eman K. A.
    Labib, Madlen B.
    Fadaly, Wael A. A.
    Zidan, Taha H.
    BIOORGANIC CHEMISTRY, 2020, 105
  • [29] Anti-inflammatory effects of selective COX-2 inhibitors
    Süleyman, H
    Demircan, B
    Karagöz, Y
    Öztasan, N
    Süleyman, B
    POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (06): : 775 - 780
  • [30] Lumiracoxib (Prexige®):: a new selective cox-2 inhibitor
    Mysler, E
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (06) : 606 - 611